Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 257

1.

The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male Subjects.

Halberg IB, Lyby K, Wassermann K, Heise T, Plum-Mörschel L, Zijlstra E.

Clin Pharmacokinet. 2019 May 16. doi: 10.1007/s40262-019-00772-2. [Epub ahead of print]

PMID:
31093929
2.

Better glycaemic control with BioChaperone glargine lispro co-formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes.

Meiffren G, Herbrand T, Anastassiadis E, Klein O, DeVries JH, Heise T, Alluis B, Mégret C, Gaudier M, Soula O, Plum-Mörschel L.

Diabetes Obes Metab. 2019 Mar 3. doi: 10.1111/dom.13685. [Epub ahead of print]

PMID:
30828929
3.

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial.

Halberg IB, Lyby K, Wassermann K, Heise T, Zijlstra E, Plum-Mörschel L.

Lancet Diabetes Endocrinol. 2019 Mar;7(3):179-188. doi: 10.1016/S2213-8587(18)30372-3. Epub 2019 Jan 21.

PMID:
30679095
4.

Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2.

van den Bijgaart RJE, Kroesen M, Wassink M, Brok IC, Kers-Rebel ED, Boon L, Heise T, van Scherpenzeel M, Lefeber DJ, Boltje TJ, den Brok MH, Hoogerbrugge PM, Büll C, Adema GJ.

J Biol Chem. 2019 Mar 22;294(12):4437-4449. doi: 10.1074/jbc.RA118.002763. Epub 2019 Jan 22.

PMID:
30670592
5.

Comparison of three meta-analytic methods using data from digital interventions on type 2 diabetes.

Kebede MM, Peters M, Heise TL, Pischke CR.

Diabetes Metab Syndr Obes. 2018 Dec 19;12:59-73. doi: 10.2147/DMSO.S180106. eCollection 2019.

6.

Concentrated insulins in current clinical practice.

Schloot NC, Hood RC, Corrigan SM, Panek RL, Heise T.

Diabetes Res Clin Pract. 2019 Feb;148:93-101. doi: 10.1016/j.diabres.2018.12.007. Epub 2018 Dec 21. Review.

7.

BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study.

Heise T, Meiffren G, Alluis B, Seroussi C, Ranson A, Arrubla J, Correia J, Gaudier M, Soula O, Soula R, DeVries JH, Klein O, Bode B.

Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13621. [Epub ahead of print]

PMID:
30565407
8.

Potent Metabolic Sialylation Inhibitors Based on C-5-Modified Fluorinated Sialic Acids.

Heise T, Pijnenborg JFA, Büll C, van Hilten N, Kers-Rebel ED, Balneger N, Elferink H, Adema GJ, Boltje TJ.

J Med Chem. 2019 Jan 24;62(2):1014-1021. doi: 10.1021/acs.jmedchem.8b01757. Epub 2018 Dec 31.

9.

In vitro proteomic analysis of methapyrilene toxicity in rat hepatocytes reveals effects on intermediary metabolism.

Braeuning A, Oberemm A, Heise T, Gundert-Remy U, Hengstler JG, Lampen A.

Arch Toxicol. 2019 Feb;93(2):369-383. doi: 10.1007/s00204-018-2360-3. Epub 2018 Nov 22.

PMID:
30467583
10.

The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathway.

Knebel C, Heise T, Zanger UM, Lampen A, Marx-Stoelting P, Braeuning A.

Food Chem Toxicol. 2019 Jan;123:481-491. doi: 10.1016/j.fct.2018.11.039. Epub 2018 Nov 17.

PMID:
30458266
11.

Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus.

Haahr H, Pieber TR, Mathieu C, Gondolf T, Shiramoto M, Erichsen L, Heise T.

Clin Pharmacokinet. 2019 May;58(5):639-649. doi: 10.1007/s40262-018-0718-6.

12.

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus.

Hövelmann U, Olsen MB, Mouritzen U, Lamers D, Kronshage B, Heise T.

Diabetes Obes Metab. 2019 Mar;21(3):601-610. doi: 10.1111/dom.13562. Epub 2018 Nov 28.

PMID:
30350477
13.

Voluntary industry initiatives to promote healthy diets: a case study on a major European food retailer.

von Philipsborn P, Stratil JM, Heise TL, Landgraf R, Hauner H, Rehfuess EA.

Public Health Nutr. 2018 Dec;21(18):3469-3476. doi: 10.1017/S1368980018002744. Epub 2018 Oct 18.

PMID:
30334511
14.

Environmental effects of ambient temperature and relative humidity on insulin pharmacodynamics in adults with type 1 diabetes mellitus.

Al-Qaissi A, Papageorgiou M, Javed Z, Heise T, Rigby AS, Garrett AT, Hepburn D, Kilpatrick ES, Atkin SL, Sathyapalan T.

Diabetes Obes Metab. 2019 Mar;21(3):569-574. doi: 10.1111/dom.13555. Epub 2018 Nov 4.

PMID:
30311402
15.

Propiconazole is an activator of AHR and causes concentration additive effects with an established AHR ligand.

Knebel C, Kebben J, Eberini I, Palazzolo L, Hammer HS, Süssmuth RD, Heise T, Hessel-Pras S, Lampen A, Braeuning A, Marx-Stoelting P.

Arch Toxicol. 2018 Dec;92(12):3471-3486. doi: 10.1007/s00204-018-2321-x. Epub 2018 Oct 6.

16.

Effectiveness of Digital Interventions for Improving Glycemic Control in Persons with Poorly Controlled Type 2 Diabetes: A Systematic Review, Meta-analysis, and Meta-regression Analysis.

Kebede MM, Zeeb H, Peters M, Heise TL, Pischke CR.

Diabetes Technol Ther. 2018 Nov;20(11):767-782. doi: 10.1089/dia.2018.0216. Epub 2018 Sep 26.

PMID:
30257102
17.

Considering Blood Dilution improves the Precision of Continuous Whole Blood Glucose Measurements.

Benesch C, Kuhlenkötter M, Heise T.

J Diabetes Sci Technol. 2018 Sep 26:1932296818803621. doi: 10.1177/1932296818803621. [Epub ahead of print]

PMID:
30255710
18.

Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project.

Schliess F, Heise T, Benesch C, Mianowska B, Stegbauer C, Broge B, Gillard P, Binkley G, Crône V, Carlier S, Delval C, Petkov A, Beck JP, Lodwig V, Gurdala M, Szecsenyi J, Rosenmöller M, Cypryk K, Mathieu C, Renard E, Heinemann L.

J Diabetes Sci Technol. 2019 Mar;13(2):261-267. doi: 10.1177/1932296818803588. Epub 2018 Sep 21.

PMID:
30241444
19.

Selective Inhibition of Sialic Acid-Based Molecular Mimicry in Haemophilus influenzae Abrogates Serum Resistance.

Heise T, Langereis JD, Rossing E, de Jonge MI, Adema GJ, Büll C, Boltje TJ.

Cell Chem Biol. 2018 Oct 18;25(10):1279-1285.e8. doi: 10.1016/j.chembiol.2018.05.018. Epub 2018 Jul 5.

PMID:
29983272
20.

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study.

Ambery P, Parker VE, Stumvoll M, Posch MG, Heise T, Plum-Moerschel L, Tsai LF, Robertson D, Jain M, Petrone M, Rondinone C, Hirshberg B, Jermutus L.

Lancet. 2018 Jun 30;391(10140):2607-2618. doi: 10.1016/S0140-6736(18)30726-8. Epub 2018 Jun 23.

PMID:
29945727

Supplemental Content

Support Center